- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/72 - Benzo [c] thiophenesHydrogenated benzo [c] thiophenes
Patent holdings for IPC class C07D 333/72
Total number of patents in this class: 85
10-year publication summary
5
|
5
|
5
|
9
|
5
|
4
|
4
|
8
|
5
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Zhejiang Jingxin Pharmaceutical Co., Ltd. | 22 |
6 |
BASF SE | 20580 |
4 |
Merck Patent GmbH | 5877 |
4 |
Shanghai Jingxin Biomedical Co., Ltd. | 16 |
4 |
Ambrx, Inc. | 193 |
3 |
Shangyu Jingxin Pharmaceutical Co., Ltd. | 9 |
3 |
Syngenta Participations AG | 2715 |
2 |
Duke University | 3035 |
2 |
Actelion Pharmaceuticals Ltd | 552 |
2 |
Chugai Seiyaku Kabushiki Kaisha | 1322 |
2 |
Kyushu University, National University Corporation | 1636 |
2 |
Nippon Kayaku Kabushiki Kaisha | 1432 |
2 |
Ryvu Therapeutics SA | 40 |
2 |
Shanghai Jingxin Biology & Pharmaceutical Co., Ltd. | 7 |
2 |
Glaxo Group Limited | 4218 |
1 |
Novartis AG | 11202 |
1 |
Samsung Electronics Co., Ltd. | 140839 |
1 |
LG Chem, Ltd. | 17685 |
1 |
The Regents of the University of California | 19654 |
1 |
Janssen Pharmaceutica N.V. | 3582 |
1 |
Other owners | 39 |